glp-1 receptor agonists weight loss Medications for Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Potential Use of GLP-1 and
Description
Erratum in: N Engl J Med
Under standard review timelines, that places potential FDA approval somewhere around mid to late next year
doi: 10.1111/add.16065, 50 GearhardtA
Deo SV, Marsia S, McAllister DA, Elgudin Y, Sattar N, Pell JP
Furthermore, retaliatory tariffs imposed by other countries on US-manufactured pharmaceuticals could impact the export opportunities for US companies in the global GLP-1 receptor agonist market
A clinical trial is currently underway exploring the physiological effects of exenatide in reducing ICP in a small cohort of active patients with IIH
